BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9156590)

  • 1. [MR venography of the deep leg veins: signal enhancement by volume infusion].
    König CW; Kaiser WA
    Rofo; 1997 Mar; 166(3):206-9. PubMed ID: 9156590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-enhanced body MR venography with subtraction technique.
    Lebowitz JA; Rofsky NM; Krinsky GA; Weinreb JC
    AJR Am J Roentgenol; 1997 Sep; 169(3):755-8. PubMed ID: 9275892
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
    Rofsky NM; Purdy DE; Johnson G; DeCorato DR; Earls JP; Krinsky G; Weinreb JC
    Radiology; 1997 Jan; 202(1):177-82. PubMed ID: 8988209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced subtraction MR angiography of the lower extremities: initial evaluation with a multisection two-dimensional time-of-flight sequence.
    Adamis MK; Li W; Wielopolski PA; Kim D; Sax EJ; Kent KC; Edelman RR
    Radiology; 1995 Sep; 196(3):689-95. PubMed ID: 7644630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three-phase gadolinium infusion in moving-table three-dimensional MR angiography].
    Kita M; Mitani Y; Tanihata H; Sato M; Takizawa O; Laub G
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Dec; 59(14):888-90. PubMed ID: 10655715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
    Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
    J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
    Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
    Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state and dynamic MR angiography with MS-325: initial experience in humans.
    Grist TM; Korosec FR; Peters DC; Witte S; Walovitch RC; Dolan RP; Bridson WE; Yucel EK; Mistretta CA
    Radiology; 1998 May; 207(2):539-44. PubMed ID: 9577507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of a contrast-medium supported 3D MR-angiography in respiratory arrest following optimization of contrast medium bolus].
    Kopka L; Vosshenrich R; Müller D; Fischer U; Rodenwaldt J; Grabbe E
    Rofo; 1997 Apr; 166(4):290-5. PubMed ID: 9198491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
    Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR
    J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of similarity mapping and eigenimaging as applied to dynamic MR imaging of a low grade astrocytoma.
    Rogowska J; Preston K; Aronen HJ; Wolf GL
    Acta Radiol; 1994 Jul; 35(4):371-7. PubMed ID: 8011388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gd-enhanced subtraction MR venography].
    Hoshi T; Hachiya T; Kanauchi T; Hando Y; Homma T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):674-8. PubMed ID: 10565170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-resolved contrast-enhanced pulmonary MR angiography using sensitivity encoding (SENSE).
    Ohno Y; Kawamitsu H; Higashino T; Takenaka D; Watanabe H; van Cauteren M; Fujii M; Hatabu H; Sugimura K
    J Magn Reson Imaging; 2003 Mar; 17(3):330-6. PubMed ID: 12594723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA).
    Enden T; Storås TH; Negård A; Haig Y; Sandvik L; Gjesdal KI; Sandset PM; Kløw NE
    J Magn Reson Imaging; 2010 Feb; 31(2):416-24. PubMed ID: 20099355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gadolinium-DTPA (Magnevist) as contrast medium for arterial DSA].
    Schild HH; Weber W; Boeck E; Mildenberger P; Strunk H; Düber C; Grebe P; Schadmand-Fischer S; Thelen M
    Rofo; 1994 Mar; 160(3):218-21. PubMed ID: 8136474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The magnetic resonance tomography of osteochondrosis dissecans of the knee joint after intravenous gadolinium-DTPA administration].
    Adam G; Neuerburg J; Peiss J; Bohndorf K; Günther RW
    Rofo; 1994 May; 160(5):459-64. PubMed ID: 8173056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.